FDA clears emergency use of lab-made antibodies to treat COVID-19

The FDA just cleared a medical advance that could play an important (if limited) role in treating COVID-19 patients. The administration has granted emergency use authorization for Regeneron’s lab-made monoclonal antibodies (a combo of casirivimab and...

Universal Flu Vaccine to End Seasonal Flu Shots


Is the end of seasonal flu shots in sight? Scientists from The Scripps Research Institute (TSRI) and the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) discovered a way to induce...